Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch...
System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(21)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Jul 05, 2023 10:36am
RE:Very POSITIVE CTV news report.
I agree, it was a strong interview and response from PT. Just wish they could break out such interviews Canada-wide instead of being funnelled solely through local London CTV. Or am I wrong...did
...more
(115)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Jul 02, 2023 7:03pm
Very POSITIVE CTV news report.
CTV news interviewed P.T and showed what SVA's pouch can do. Very factual report!! I can see a new 52 week high coming soon.
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(1530)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Jun 30, 2023 11:29am
Leede Jones Gable - cantechletter.com
By Jayson MacLean Published on June 30, 2023 Last Updated on June 30, 2023 Filed under: All posts, Analysts, Pharma and Biotech Stock: sva Sernova is a
...more
(115)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Jun 26, 2023 7:23pm
RE:RE:More POSITIVE NEWS out this morning
SVA shares were in the 80s before rumours of this announcement pushed it over a buck. Now that news is out people are selling. Buy on rumour sell on news. I'm not worried.
(10)
•••
Kiwi11
X
View Profile
View Bullboard History
Comment by
Kiwi11
on Jun 26, 2023 2:53pm
RE:More POSITIVE NEWS out this morning
Market certainly didn't like the news.
(115)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Jun 26, 2023 8:04am
More POSITIVE NEWS out this morning
After so many years, SVA has now reached a level where a buyout will likely happen within the next few years.. No, I don't have any inside info, but owning this for so soooooooo long, you can see
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 26, 2023 7:50am
New Press Release - Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System(TM) at American Diabetes Association 83rd Scientific Sessions
In the first cohort of the ongoing Phase 1/2 clinical trial, the first 5 patients to complete protocol-defined islet transplants achieved insulin-independence for ongoing periods of 6 to 38 months.Following islet transplants to the 8-channel Cell Pouches, patients in the first cohort required...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 22, 2023 5:17pm
New Press Release - Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System(TM) During Oral Presentation at American Diabetes Association 83rd Scientific Sessions
Company to host in-person only analyst and investor event at an offsite location following the presentation on Saturday, June 24 at the ADA Scientific Sessions LONDON, Ontario, June 22, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company...
read article.
(115)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Jun 20, 2023 7:45am
SERNOVA TO RAISE C$10M
Sernova to raise C$10M https://seekingalpha.com/news/3658137-sernova-to-raise-c10m I know I know, it's old news, but funds were raised over 2 years ago at $1.20. SVA is worth at least
...more
(1530)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Jun 19, 2023 3:34pm
Research Capital starts covergae- cantechletter.com
By Jayson MacLean Published on June 19, 2023 Last Updated on June 19, 2023 Filed under: All posts, Analysts, Pharma and Biotech Stock: sva Sernova is a four
...more
(115)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Jun 13, 2023 4:29pm
RE:RE:RE:RE:RE:Astrazeneca diabetes?
They're all over on another board. And there's one on that board that took my username. (Cough cough bioteck cough) lol.
(376)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Jun 12, 2023 3:57pm
RE:RE:RE:RE:Astrazeneca diabetes?
being a past share holder I look in every so often just in case (I might want to buy again). rixpix, sort of funny, since your post there hasn't been any posts. They must be scared of you. LOL
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 31, 2023 7:00am
New Press Release - Sernova Announces Executive Alignment and Appoints New Board Chair
LONDON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, today announced the outcomes from a strategic and executive leadership review conducted by its Board of Directors (the “Board”). ...
read article.
(115)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on May 04, 2023 5:14pm
RE:RE:RE:Astrazeneca diabetes?
I laugh and SMH every time I see someone telling others not to post, or what to post. Lol.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth